Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

GSK - The breakthrough era in endometrial cancer treatment

Surge in molecular-based targets brings new hope for EC treatment

Date

22 Oct 2023

Session

GSK - The breakthrough era in endometrial cancer treatment

Topics

Tumour Site

Endometrial Cancer

Presenters

All Speakers

Authors

C. Marth1, I. Colombo2, K.N. Moore3, A. Speakers4

Author affiliations

  • 1 Department Of Obstetrics And Gynecology, Innsbruck Medical University, A-6020 - Innsbruck/AT
  • 2 EOC - Ospedale Regionale di Bellinzona e Valli, San Giovanni, 6500 - Bellinzona/CH
  • 3 Department Of Obstetrics And Gynecology University, Stephenson Cancer Center/University of Oklahoma, 73104 - Oklahoma City/US
  • 4 ESMO - European Society for Medical Oncology, GX11 1AA - Lugano/CH

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Full discussion/Q&A

Presenter: All Speakers

Session: GSK - The breakthrough era in endometrial cancer treatment

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.